A detailed history of Skopos Labs, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 3,584 shares of ZTS stock, worth $629,708. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,584
Previous 3,280 9.27%
Holding current value
$629,708
Previous $568,000 23.24%
% of portfolio
0.23%
Previous 0.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $52,464 - $59,729
304 Added 9.27%
3,584 $700,000
Q1 2024

May 06, 2024

SELL
$165.67 - $199.94 $38,932 - $46,985
-235 Reduced 6.69%
3,280 $548 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $532,311 - $703,316
3,515 New
3,515 $694 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.3B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Skopos Labs, Inc. Portfolio

Follow Skopos Labs, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Skopos Labs, Inc. with notifications on news.